Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BRC-20 meme coin PARTY has increased by 40.89% in the last 24 hours

BRC-20 meme coin PARTY has increased by 40.89% in the last 24 hours

Bitget2024/12/27 08:09

On December 27, the BRC-20 meme coin PARTY saw a 24-hour increase of 40.89%, with a trading volume reaching $1.8 million and 11,884 transactions. The current liquidity pool has exceeded $13.6 million.
PARTY was launched by the Bitcoin MEME launch platform BTC.Fun, which relies on the ecological advantages of Merlin Chain to provide users with low gas fee layer one and two Runes/BRC20 token issuance and trading services. It is reported that BTC.Fun will continue to carry out a series of ecological construction activities to further enhance platform activity and user participation, with the official version set to go live soon.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.

Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.

华尔街见闻•2026/10/26 05:56
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.